External Control, Observational, Retrospective Study Comparing Pralsetinib to Best Available Therapy in Patients With RET-Fusion Positive NSCLC

Name: External Control, Observational, Retrospective Study Comparing Pralsetinib to Best Available Therapy in Patients With RET-Fusion Positive NSCLC
Published: 2020
License: Public Domain

Blueprint Medicines Corporation · 2020

ClinicalTrials.gov · Datasets · License: Public Domain · 2020

Open Source ↗

carcinoma head-and-neck-neoplasms neoplasms

ret-fusion non small cell lung cancer, lung neoplasm, carcinoma, non-small-cell lung, respiratory tract neoplasms, thoracic neoplasms, neoplasms by site, neoplasms, lung diseases, respiratory tract diseases, carcinoma, bronchogenic, bronchial diseases, head and neck neoplasms

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 856971
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.